$258.44
-1.23-0.47%
Last update: Nov 10, 4:00 PM
Quest Diagnostics Inc
DGXNYSE
Quest Diagnostics rose 40.9% from $184.31 to a 1-year high of $259.67, ahead of the S&P 500's +10.0%. Its worst day was Sep 22 (−4.1%), and its low came Jan 5 at $173.49.
Nov 10, 2025 – Nov 9, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
Quest Diagnostics closed at its lowest level of the year, 5.9% below where the year started.
−0.2% · S&P 500 +0.7%
EPS of $2.42 beat the $2.35 estimate on $2.8B revenue (est. $2.8B); FY revenue guidance of $11.7B–$11.8B against the $11.4B consensus.
Story events cover the past 12 months · Times ET
+7.4% · S&P 500 −0.3%
EPS of $2.50 beat the $2.36 estimate on $2.9B revenue (est. $2.8B); FY revenue guidance of $11.8B–$11.9B against the $11.8B consensus.
+4.4% · S&P 500 −0.7%
EPS of $3.12 beat the $2.82 estimate on $3.0B revenue (est. $3.0B); FY revenue guidance of $11.9B–$12.1B against the $11.9B consensus.
+8.6%, the year's best day, on 4M shares, the year's heaviest volume · S&P 500 −1.2%
CMS proposes 2027 Medicare lab rates, estimating $1 billion in annual taxpayer savings as payments align with private rates.
−4.1%, the year's worst day · S&P 500 0.0%
EPS of $3.00 beat the $2.87 estimate on $3.1B revenue (est. $3.0B); FY revenue guidance of $12.1B–$12.1B against the $12.0B consensus.
+1.8% · S&P 500 −1.2%
Where it ended: a 1-year high close of $259.67 on Nov 9, 2026. Up next: Q4 2026 earnings on Feb 9, 2027 (EPS est. $2.68, revenue est. $3.0B).
As of the Nov 9, 2026 close
Replay the year: the line draws itself and stops at each of the 6 moments with what happened and how the stock reacted.
Chart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for DGX and SPY from Benzinga historical bars. Not investment advice.
